
Dr. Reddy’s gets USFDA nod for generic anti-cancer drug
The Hindu
Dr. Reddy’s Laboratories has received U.S. Food and Drug Administration (USFDA) approval for a generic version of anti-cancer drug Revlimid (lenalidomide) capsules.The health regulator gave final appr
Dr. Reddy’s Laboratories has received U.S. Food and Drug Administration (USFDA) approval for a generic version of anti-cancer drug Revlimid (lenalidomide) capsules.
The health regulator gave final approval for the company’s ANDA (abbreviated new drug application for Lenalidomide capsules), 2.5 mg and 20 mg strengths and tentative approval for 5 mg, 10 mg, 15 mg and 25 mg strengths. With the approval, the company will be eligible for 180 days of generic drug exclusivity for Lenalidomide capsules 2.5 mg and 20 mg, Dr. Reddy’s said in a release on Tuesday.
“We are pleased with the approval of Lenalidomide capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity... look forward to bringing a more affordable generic version of this drug to market,” said Marc Kikuchi, CEO-North America Generics.

Inspired by deeply personal memories, says maker of Telugu short selected for Sundance Film Festival
Telugu short film "O’sey Balamma," inspired by childhood memories, selected for Sundance Film Festival 2026, says creator Nimmala Raman.

The Union and State governments provided support in several ways to the needy people, but private institutions should also extend help, especially to those requiring medical assistance, said C.P. Rajkumar, Managing Director, Nalam Multispeciality Hospital, here on Saturday. Speaking at a function to honour Inspector General of Police V. Balakrishnan and neurologist S. Meenakshisundaram with C. Palaniappan Memorial Award for their contribution to society and Nalam Kappom medical adoption of Type-1 diabetic children, he said the governments implemented numerous welfare programmes, but the timely help by a private hospital or a doctor in the neighbourhood to the people in need would go a long way in safeguarding their lives.











